Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04585269
Other study ID # Pro2019002928
Secondary ID 1R37CA240807-01A
Status Recruiting
Phase N/A
First received
Last updated
Start date February 10, 2021
Est. completion date April 2026

Study information

Verified date January 2024
Source Rutgers, The State University of New Jersey
Contact Rutgers ClinicalTrials.gov PRS Administrator
Phone 973-972-1149
Email chennr@ored.rutgers.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this project is to evaluate efficacy of Bright IDEAS, an evidence-based problem-solving skills training (PSST) program, as a supportive care intervention for young adult (YA) cancer patients compared with enhanced usual psychosocial care with 344 young adult patients newly diagnosed with cancer.


Description:

Bright IDEAS-YA is a personalized approach to increase problem-solving ability by fostering positive appraisal of problems as solvable challenges that can be overcome and enhancing rational problem-solving skills to systematically work through any problem. Bright IDEAS-YA intervention consists of six 45-minute one-on-one sessions with a trainer who teaches the participant the Bright IDEAS stepwise approach to problem-solving and guides the participant through solving their own problems using the Bright IDEAS approach. Up to 344 young adult patients newly diagnosed with cancer will be recruited to participate in this multi-site randomized controlled trial, where the Bright IDEAS-YA intervention will be compared with enhanced usual psychosocial care. Efficacy will be evaluated by examining changes in psychosocial outcomes from baseline to post-intervention (3 months) and follow-up (6, 12 and 24 months). The extent to which changes in aspects of problem-solving ability mediate the intervention effects will be examined.


Recruitment information / eligibility

Status Recruiting
Enrollment 344
Est. completion date April 2026
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - Current age 18-39 - Within 4 months of first diagnosis of any cancer - Cancer being treated with chemotherapy and/or radiation therapy and/or hematopoietic stem cell transplant - No documented or self-reported cognitive delay or impairment that would prevent completion of survey measures - English-speaking Exclusion Criteria: - Medical crisis or not receiving curative therapy per physician/treatment team report - Treatment involves surgery only

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Bright IDEAS-YA
Bright IDEAS-YA is a manualized problem-solving skills training intervention conducted by a trainer who teaches the participant the Bright IDEAS stepwise approach to problem-solving and guides the participant through solving their own problems using the Bright IDEAS approach.

Locations

Country Name City State
United States Rutgers Cancer Institute of New Jersey New Brunswick New Jersey
United States Memorial Sloan Kettering Cancer Center New York New York
United States H. Lee Moffitt Cancer Center and Research Institute Tampa Florida

Sponsors (5)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI), University of Rochester

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Comprehensive Score for Financial Toxicity (COST) Those who indicate financial responsibility will respond to the full 11-item scale of financial toxicity associated with cancer treatment. Respondents rate each item on a 5-point Likert scale from 0 (not at all) to 4 (very much) in the past 7 days. The measure yields a total summary score, with higher scores indicating greater financial strain. Baseline, Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
Other Unmet needs and concerns measured by the Adolescent and Young Adult Oncology Screening Tool (adapted version - young adults) Participants first rate their distress on a 0-10 scale. Higher score indicates higher distress. Next, they are asked to check off areas of concern from the past week, including practical (e.g., housing arrangements, work, bills, transportation), family (e.g., parents, siblings, partner), emotional (e.g., sadness, isolation, guilt), social (e.g., isolation from friends, missing important events), physical (e.g., body image, sexual concerns, sleeping difficulty), and informational (e.g., understanding information, feeling involved in decision-making) needs. A total score from 0 to 51 is calculated. Baseline, Time 2 (about 3 months from baseline), Time 3 (about 6 months from baseline), Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
Other Social Problem-Solving Inventory-Revised Short Form (SPSI-R:S) This 25-item self-report measure of five theoretically-important constructs of everyday problem-solving, including positive problem orientation, negative problem orientation, rational problem-solving style, impulsive/carelessness style, and avoidant style. Respondents answer each item on 5-point Likert scale from 0 (not at all true of me) to 4 (extremely true of me). Summary scores ranging from 0-20 are computed for each subscale, as well as an overall score. A higher Total score indicates better problem-solving ability. Baseline, Time 2 (about 3 months from baseline), Time 3 (about 6 months from baseline), Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
Other PROMIS Social Isolation - Short Form 4a This four-item measure assesses perceptions of social isolation on a 5-point scale from 1 (never) to 5 (always) in the past 7days. Higher scores indicating higher levels of perceived isolation. Baseline, Time 2 (about 3 months from baseline), Time 3 (about 6 months from baseline), Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
Other Support Services Received Participants will check whether they have used or received services in the following categories: psychosocial support, informational and practical support, fertility or sexual health, physical/wellness services and integrative medicine services. Baseline, Time 2 (about 3 months from baseline), Time 3 (about 6 months from baseline), Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
Other Satisfaction with intervention derived from the Multi-Dimensional Treatment Satisfaction Measure Ten-item scale assesses utility of intervention-specific components (e.g., the user manual, worksheets), attitude towards the intervention, trainer competence, and perceived benefit attributable to the intervention. Participants will answer on a 5 point scale, from 0 (strongly disagree) to 4 (strongly agree) with higher scores indicating higher satisfaction. This measure will be administered at post-intervention to intervention arm only. Time 2 (about 3 months from baseline).
Primary Change in Symptoms of Depression, as Measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short-Form (v1.0 8a) Respondents report symptoms on a 5-point rating scale from 1 "never" to 5 "always" in the past 7 days, with higher scores indicating higher levels of negative affect. A total raw summary score is calculated and then translated into a standardized T-score with a mean of 50 and standard deviation of 10. From Baseline to Time 3 (about 6 months from baseline)
Primary Change in Symptoms of Anxiety, as Measured by the PROMIS Anxiety Short-Form (v1.0 8a) Respondents report symptoms on a 5-point rating scale from 1 "never" to 5 "always" in the past 7 days, with higher scores indicating higher levels of negative affect. A total raw summary score is calculated and then translated into a standardized T-score with a mean of 50 and standard deviation of 10. From Baseline to Time 3 (about 6 months from baseline)
Primary Change in Functional Assessment of Cancer Therapy - General (FACT-G v4) This 27-item measures health-related quality of life and yields an overall General Total score and four subscales: Physical Well-Being (PWB), Social/Family Well-Being (SWB), Emotional Well-Being (EWB) and Functional Well-Being (FWB). Respondents rate each item on 5-point Likert scale from 0 (not at all) to 4 (very much) in the past 7 days, where higher numbers indicate higher health state. Each scale is a summary of responses, ranging from 0 to 28 for PWB, SWB, and FWB, 0 to 24 for EWB, and 0 to 108 for General Total. From Baseline to Time 3 (about 6 months from baseline)
Secondary Symptoms of Depression, as Measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short-Form (v1.0 8a) Respondents report symptoms on a 5-point rating scale from 1 "never" to 5 "always" in the past 7 days, with higher scores indicating higher levels of negative affect. A total raw summary score is calculated and then translated into a standardized T-score with a mean of 50 and standard deviation of 10. Baseline, Time 2 (about 3 months from baseline), Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
Secondary Symptoms of Anxiety, as Measured by the PROMIS Anxiety Short-Form (v1.0 8a) Respondents report symptoms on a 5-point rating scale from 1 "never" to 5 "always" in the past 7 days, with higher scores indicating higher levels of negative affect. A total raw summary score is calculated and then translated into a standardized T-score with a mean of 50 and standard deviation of 10. Baseline, Time 2 (about 3 months from baseline), Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
Secondary Functional Assessment of Cancer Therapy - General (FACT-G v4) This 27-item measures health-related quality of life and yields an overall General Total score and four subscales: Physical Well-Being (PWB), Social/Family Well-Being (SWB), Emotional Well-Being (EWB) and Functional Well-Being (FWB). Respondents rate each item on 5-point Likert scale from 0 (not at all) to 4 (very much) in the past 7 days, where higher numbers indicate higher health state. Each scale is a summary of responses, ranging from 0 to 28 for PWB, SWB, and FWB, 0 to 24 for EWB, and 0 to 108 for General Total. Baseline, Time 2 (about 3 months from baseline), Time 4 (about 12 months from baseline), Time 5 (about 24 months from baseline).
See also
  Status Clinical Trial Phase
Completed NCT03707548 - BPT to Improve Bodily Disturbances in Post-treatment Cancer Patients N/A
Not yet recruiting NCT04493450 - NEMO - an App for Side Effect Management in Oncology
Completed NCT05604820 - The Effect of Progressive Muscle Relaxation Exercise on Sleep Quality N/A
Completed NCT04024748 - Verification of Imaging System PCD-1000A
Completed NCT03320161 - A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project
Recruiting NCT05547282 - Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure N/A
Recruiting NCT01742143 - Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Completed NCT05368116 - Effectiveness of Video Assisted Self Management Program on Chemotherapy Related Side Effects . N/A
Recruiting NCT01603316 - Food: A Three-Arm Study Examining Food Insecurity Interventions Phase 2
Recruiting NCT03100071 - Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
Completed NCT04037410 - Environmental Temperature and White Adipose Tissue in Cancer Patients
Recruiting NCT06305741 - A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers N/A
Recruiting NCT05279378 - Correlation of Lung Ultrasonography With Chest CT Findings in Cancer Patients With COVID-19 Viral Pneumonia
Completed NCT03536702 - Effect of Group Led Creative Writing on Mood in Cancer Patients N/A
Not yet recruiting NCT05922423 - Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence N/A
Completed NCT01704469 - A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients N/A
Active, not recruiting NCT06348940 - Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patients N/A
Completed NCT04302792 - New Food Solutions for Cancer Patients N/A
Recruiting NCT05219851 - The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
Completed NCT05884047 - The Effect Of Virtual Reality Glasses On Vital Signs And State Anxiety Level In Cancer Patients N/A